Convalescent Plasma in a Patient with Protracted COVID-19 and Secondary Hypogammaglobulinemia Due to Chronic Lymphocytic Leukemia: Buying Time to Develop Immunity?

• Váldodahkkit: Jaap L. J. Hanssen (Dahkki), Johan Stienstra (Dahkki), Stefan A. Boers (Dahkki), Cilia R. Pothast (Dahkki), Hans L. Zaaijer (Dahkki), Jennifer M. Tjon (Dahkki), Mirjam H. M. Heemskerk (Dahkki), Mariet C. W. Feltkamp (Dahkki), Sandra M. Arend (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: MDPI AG, 2021-09-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

It is not exactly clear yet which type of immune response prevails to accomplish viral clearance in coronavirus disease 2019 (COVID-19). Studying a patient with chronic lymphocytic leukemia and hypogammaglobulinemia who suffered from COVID-19 provided insight in the immunological responses after tre...